Insulet PODD
NASDAQ PODD
$134.90 -3.02 (-2.19%)
As of: Sep 10, 2026 · 2:52 PM EDT

Insulet (PODD) Cash from Financing Activities (2010 - 2026)

Insulet's (PODD) quarterly Cash from Financing Activities came in at $4.0 million in Q2 2026, up 101.16% on a YoY basis from $2.0 million in Q2 2025, and up 101.25% quarter-over-quarter from -$319.9 million in Q1 2026.

Analysis

Insulet (PODD) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Cash from Financing Activities for 17 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash from Financing Activities rose 101.16% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2026 stood at -$845.4 million (down 855.25% YoY), and the FY2025 full-year result was -$595.3 million, down 2026.07% from the prior year.
  • Cash from Financing Activities advanced to $4.0 million in Q2 2026 per PODD's latest filing, from -$319.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $277.7 million in Q1 2025 and bottomed at -$457.0 million in Q3 2025.
  • Historically, Cash from Financing Activities has averaged -$55.2 million across 5 years, with a median of -$9.5 million in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 2069.5% in 2025, down 23952.63% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$14.5 million in 2022, then jumped by 115.17% to $2.2 million in 2023, then sank by 1045.45% to -$20.8 million in 2024, then sank by 248.56% to -$72.5 million in 2025, then jumped by 105.52% to $4.0 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $4.0 million, -$319.9 million, and -$72.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn -343.00 Mn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn -300,000.00
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn -607.30 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn -213.50 Mn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn 4.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Mar 31, 2026 -319.90 Mn
Dec 31, 2025 -72.50 Mn
Sep 30, 2025 -457.00 Mn
Jun 30, 2025 -343.50 Mn
Mar 31, 2025 277.70 Mn
Dec 31, 2024 -20.80 Mn
Sep 30, 2024 -1.90 Mn
Jun 30, 2024 8.80 Mn
Mar 31, 2024 -14.10 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 -6.90 Mn
Jun 30, 2023 3.20 Mn
Mar 31, 2023 -12.10 Mn
Dec 31, 2022 -14.50 Mn
Sep 30, 2022 -3.90 Mn
Jun 30, 2022 -1.60 Mn
Mar 31, 2022 -20.30 Mn
Dec 31, 2021 -1.50 Mn
Sep 30, 2021 42.20 Mn